Prudential Financial’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Prudential Financial’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34,250	Closed	-$825K	–	2770
2023 Q1	$825K	Buy	34,250 +300	+0.9%	+$3.77K	﹤0.01%	1836
2022 Q4	$359K	Buy	33,950 +450	+1%	+$3.63K	﹤0.01%	2174
2022 Q3	$151K	Hold	33,500	–	–	﹤0.01%	2485
2022 Q2	$134K	Buy	+33,500	New	+$159K	﹤0.01%	2505
2022 Q1	–	Sell	-25,300	Closed	-$142K	–	2719
2021 Q4	$142K	Buy	+25,300	New	+$161K	﹤0.01%	2568

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Prudential Financial's PRVB Position: Q2 2023 in Review

Prudential Financial sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 34,250 shares — an estimated $825K sold.

Prudential Financial first reported a position in PRVB in Q4 2021 and held it in 5 quarters. The position peaked at $825K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Prudential Financial reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Prudential Financial sold 34,250 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $825K.
Prudential Financial first reported a position in Provention Bio, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
Prudential Financial's Provention Bio, Inc. Common Stock position peaked at $825K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Prudential Financial's 13F filing for Q2 2023, filed 11 Aug 2023.